Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sichuan Biokin Pharmaceutical Co Ltd (SBP12 HK)
Watchlist
2
Analysis
Health Care
•
Hong Kong
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Cross Asset Strategy
•
27 Feb 2024 11:51
•
Syndicated
CX Daily: Chinese Pharma Turns to Global Deals to Cure Capital Crunch
Biotech / Cover story: Chinese pharma turns to global deals to cure capital crunch After enduring the chill of a prolonged capital winter, China’s...
Caixin Global
Follow
236 Views
Share
bullish
•
Baimtec Material
•
25 Feb 2024 10:00
STAR50 Index Rebalance: Three Changes a Side; One Surprise Change
There are 3 changes for the STAR50 in March. Estimated one-way turnover is 2.9% resulting in a 1-way trade of CNY 4.08bn with over 2.5x ADV to...
Brian Freitas
Follow
608 Views
Share
bearish
•
Shanghai Medicilon
•
13 Feb 2024 08:46
China Healthcare Weekly (Feb.12) - New Pricing Mechanism for Drugs, China Biotech M&A, Medicilon
NHSA released regulations to establish new mechanism for pricing newly listed chemical drugs. It would be difficult for Chinese biotech to be...
Xinyao (Criss) Wang
Follow
412 Views
Share
bearish
•
Suzhou Novosense Microelectron
•
01 Feb 2024 07:18
STAR50 Index Rebalance Preview: Sustaining Outperformance on Expected Impact
There could be 3 changes for the STAR50 Index in March. One-way turnover is estimated at 2.4% leading to a one-way trade of CNY 2.9bn. The...
Brian Freitas
Follow
618 Views
Share
bearish
•
Remegen
•
23 Jan 2024 08:55
Remegen (9995.HK/688331.CH) - The Real Reasons for the Stock Price Collapse and the Future Prospects
RemeGen's 23Q4 results will miss expectation, leading to poor performance for 2023.The pain point isn't cashflow shortage but weak...
Xinyao (Criss) Wang
Follow
356 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.49.0
x